Primary Mediastinal B-Cell Lymphoma (PMBCL) Latest Advances
Find the Latest Research About Primary Mediastinal B-Cell Lymphoma (PMBCL)
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 401 publications
Treatment intensification does not improve outcomes beyond rituximab-based therapy in primary mediastinal B-cell lymphoma: a multicenter retrospective analysis.
Journal: Leukemia & lymphoma
Published: June 10, 2026
Extensive Isolated Intracranial Recurrence of Primary Mediastinal B-Cell Lymphoma on FDG PET Imaging.
Journal: Clinical nuclear medicine
Published: March 04, 2026
Primary mediastinal B-cell lymphoma presenting as cardiac tamponade: the importance of a multimodality imaging approach
Journal: Giornale italiano di cardiologia (2006)
Published: February 25, 2026
Metabolic heterogeneity-based radiomic model predicts treatment outcomes of primary mediastinal B-cell lymphoma patients in the IELSG37 study.
Journal: British journal of haematology
Published: February 19, 2026
Primary mediastinal B-cell lymphoma: upfront high-dose chemotherapy with autologous stem cell transplantation results in favorable long-term outcome and may spare radiotherapy.
Journal: Annals of hematology
Published: January 27, 2026
First-line Polatuzumab vedotin plus R-CHP in primary mediastinal B-cell lymphoma: A real-world study bridging the gap of the POLARIX trial.
Journal: Annals of hematology
Published: January 23, 2026
Immune checkpoint therapy in pediatric and adolescent lymphomas.
Journal: Haematologica
Published: January 19, 2026
Evaluation of mTOR, NFκB and BCL-2 Inhibitor Activity In Vitro in Karpas 1106P, a Primary Mediastinal B-Cell Lymphoma Cell Line.
Journal: Hematology reports
Published: January 08, 2026
Understanding Physician Referral for Chimeric Antigen Receptor T-Cell (CAR-T) Therapy.
Journal: Journal of cancer education : the official journal of the American Association for Cancer Education
Published: January 04, 2026
Last Updated: 06/30/2026